Surgical-products manufacturer Ethicon, a Johnson & Johnson ( JNJ) company, has acquired medical-device maker Vascular Control Systems.

Privately held Vascular Control develops devices to control bleeding during obstetric and gynecologic procedures. Ethicon makes instruments for general surgery, wound management, women's health and cardiovascular surgery.

"This represents a strong, strategic fit with our gynecologic business," said Sheri McCoy, a J&J executive responsible for the Ethicon business. "The technology and knowledge we'll gain will enable us to expand our ability to create new therapies for women," she said.

Specific financial terms of the transaction weren't disclosed.

J&J's shares dipped 18 cents to $58.53 Tuesday.

If you liked this article you might like

Nationwide Egg Recall Expanded

10 Toy Fads That Have Faded

Boomers Feel Recession Burden, Blame

KFC Franchisees Want 'Fried' to Be the Focus

Heavy Weights: More Expensive, Less Effective